Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Quentin Anstee

Newcastle AuthorsTitleYearFull text
Professor Pierre Bedossa
Professor Quentin Anstee
Professor Arun Sanyal
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study2020
Professor Quentin Anstee
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe2020
Professor Arun Sanyal
Professor Quentin Anstee
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial2020
Professor Quentin Anstee
Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: a systematic review and meta-analysis2020
Dr Batoul Nasr
Professor Quentin Anstee
Dr Stuart McPherson
Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis2020
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Quentin Anstee
Professor Fiona Oakley
Bone Morphogenic Protein 8B Promotes the Progression of Non-Alcoholic Steatohepatitis2020
Professor Quentin Anstee
Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design2020
Professor Quentin Anstee
Professor Arun Sanyal
Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study2020
Professor Quentin Anstee
Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis2020
Dr Olivier Govaere
Professor Quentin Anstee
Erratum: Adverse effects of PD-1 targeted immunotherapy in NAFLD-triggered HCC2020
1234567891011121314151617181920...